NCT00892554View on ClinicalTrials.gov

The Effect of Supplemental Docosahexaenoic Acid (DHA) on Neurocognitive Outcomes in Teen and Adult Women With Phenylketonuria(PKU)

NACompletedINTERVENTIONAL
Enrollment

33

Participants

Timeline

Start Date

June 30, 2007

Primary Completion Date

January 31, 2010

Study Completion Date

January 31, 2010

Conditions
Phenylketonuria
Interventions
DIETARY_SUPPLEMENT

Docosahexaenoic Acid

Capsules providing 10 mg DHA/kg body weight/day taken once daily

DIETARY_SUPPLEMENT

Corn/soy oil

Capsules taken once daily

Trial Locations (1)

30322

Emory University, Atlanta

All Listed Sponsors
collaborator

Atlanta Clinical and Translational Science Institute

OTHER

lead

Emory University

OTHER

NCT00892554 - The Effect of Supplemental Docosahexaenoic Acid (DHA) on Neurocognitive Outcomes in Teen and Adult Women With Phenylketonuria(PKU) | Biotech Hunter | Biotech Hunter